Population-Based vs Health System and Insurer Records: Significant Underdiagnosis of PCOS - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Comparing Population Data with Health System and Insurance Records: Notable Underdiagnosis of PCOS

  • By

  • Sana Hatoum

  • Mina Amiri

  • Dawnkimberly Hopkins

  • Richard P Buyalos

  • Fernando Bril

  • Ricardo Azziz

  • January 21, 2025

Share

  • 1

    Polycystic ovary syndrome (PCOS) is a prevalent cardio-metabolic disorder in women, often underdiagnosed, leading to serious health consequences.

  • 2

    Population-based studies in the US reported PCOS prevalence between 4% and 19.6%, while health system records showed only 0.2% to 5.2%.

  • 3

    In the UK, PCOS prevalence was around 8% in the population but only 1.34% in health system records, indicating significant underdiagnosis.

  • 4

    South Korean studies showed a PCOS prevalence of 4.9% to 7% in the population compared to 0.12% to 0.33% in health system records.

  • 5

    The findings emphasize the need for improved awareness among healthcare practitioners and the public regarding PCOS diagnosis and management.

Original Source(s)

Population-Based vs Health System and Insurer Records: Significant Underdiagnosis of PCOS

  • by Sana Hatoum, Mina Amiri, Dawnkimberly Hopkins, Richard P Buyalos, Fernando Bril, Ricardo Azziz

  • January 21, 2025

Related Content

People say these peptides hurt them. Their stories are muffled in MAHA’s push for medical freedom.

“There are millions of success stories with these peptides, but no one wants to believe that this wrecks some of our lives.”

Correction: Aflibercept 8 mg in neovascular age-related macular degeneration and diabetic macular oedema: Translating clinical trials into clinical practice

Long-Term Satisfaction with the Choice to Complete Metabolic and Bariatric Surgery: The Hindsight 20/20 Study